학술논문

In vivo epigenetic crispr screen identifies asf1a as an immunotherapeutic target in kras-mutant lung adenocarcinoma
Document Type
Article
Source
In: Cancer Discovery. (Cancer Discovery, February 2020, 10(2):270-287)
Subject
Language
English
ISSN
21598290
21598274